News for Tandem Diabetes Care, Inc. (TNDM)

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

Shares of Tandem Diabetes Care Inc (TNDM) fell 2.44% in mid-day trading on Mar 3. The stock reached an intraday low of $20.84, before recovering slightly to $

Strengths: Innovative product lineup and strong market presence in insulin pump technology.Weaknesses: Heavy reliance on insulin pump sales and the challenges

Annual Worldwide Sales: $910 million, an 18% increase year over year.Fourth Quarter Sales: $252 million, over 20% growth compared to the prior year.US Fourth Q

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Q4 2024 Earnings Conference Call February 26, 2025 4:30 PM ETCompany ParticipantsSusan Morrison - Executive Vice...

While the top- and bottom-line numbers for Tandem Diabetes Care (TNDM) give a sense of how the business performed in the quarter ended December 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

Tandem Diabetes Care (TNDM) delivered earnings and revenue surprises of -76% and 1.07%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Tandem Diabetes Care Inc (TNDM), a leader in insulin delivery and diabetes technology, announced its financial results for the fourth quarter and full year endi

Quarterly Revenue: Achieved record GAAP sales of $282.6 million, surpassing the estimated $251.98 million, marking a 44% increase year-over-year.Quarterly Earn

Tandem Diabetes Care Inc (TNDM), a leader in insulin delivery and diabetes technology, has announced that its next-generation automated insulin delivery (AID) a

Evaluate the expected performance of Tandem Diabetes Care (TNDM) for the quarter ended December 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.

[url="]Tandem Diabetes Care, Inc.[/url] (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that its next-generation au

Shares of Tandem Diabetes Care Inc (TNDM) surged 5.35% in mid-day trading on Feb 25. The stock reached an intraday high of $33.20, before settling at $32.64,

PR NewswireBOSTON, Feb. 14, 2025 BOSTON, Feb. 14, 2025 /PRNewswire/ -- Below is the January 2025 Monthly Update for the Liberty All-Star Growth Fund, Inc.

BOSTON, Feb. 14, 2025 /PRNewswire/ -- Below is the January 2025 Monthly Update for the Liberty All-Star Growth Fund, Inc. (NYSE: ASG).

Beta Bionics, a company specializing in insulin delivery devices, has announced the terms of its upsized initial public offering.Based on its most recent disclo

Shares of Tandem Diabetes Care Inc (TNDM) surged 3.81% in mid-day trading on Jan 16. The stock reached an intraday high of $37.34, before settling at $37.32,

Tandem Diabetes Care Inc (TNDM), a prominent player in the insulin delivery and diabetes technology sector, has announced plans to release its fourth quarter an

PR NewswireBOSTON, Jan. 14, 2025 BOSTON, Jan. 14, 2025 /PRNewswire/ -- Below is the December 2024 Monthly Update for the Liberty All-Star Growth Fund, Inc.